The Searle Company Ltd
The Searle Company Ltd operates in Pharmaceuticals.
The Searle Company Ltd (SEARL) - Net Assets
Latest net assets as of March 2024: PKRs35.49 Billion PKR
Based on the latest financial reports, The Searle Company Ltd (SEARL) has net assets worth PKRs35.49 Billion PKR as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (PKRs66.59 Billion) and total liabilities (PKRs31.10 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | PKRs35.49 Billion |
| % of Total Assets | 53.29% |
| Annual Growth Rate | 21.57% |
| 5-Year Change | 134.31% |
| 10-Year Change | N/A |
| Growth Volatility | 17.49 |
The Searle Company Ltd - Net Assets Trend (2016–2023)
This chart illustrates how The Searle Company Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for The Searle Company Ltd (2016–2023)
The table below shows the annual net assets of The Searle Company Ltd from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-06-30 | PKRs31.68 Billion | +3.21% |
| 2022-06-30 | PKRs30.69 Billion | +17.65% |
| 2021-06-30 | PKRs26.09 Billion | +63.42% |
| 2020-06-30 | PKRs15.96 Billion | +18.07% |
| 2019-06-30 | PKRs13.52 Billion | +18.06% |
| 2018-06-30 | PKRs11.45 Billion | +16.96% |
| 2017-06-30 | PKRs9.79 Billion | +21.26% |
| 2016-06-30 | PKRs8.07 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to The Searle Company Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 233.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | PKRs14.14 Billion | 47.24% |
| Other Components | PKRs15.80 Billion | 52.76% |
| Total Equity | PKRs29.94 Billion | 100.00% |
The Searle Company Ltd Competitors by Market Cap
The table below lists competitors of The Searle Company Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CUPPF
PINK:CUPPF
|
$2.95K |
|
Tri Viet Management Investment Corp
VN:TVC
|
$2.95K |
|
NextPoint Financial Inc.
PINK:NACQQ
|
$2.95K |
|
Fourth-Link Inc.
KO:056730
|
$2.96K |
|
Eenergy Group PLC
LSE:EAAS
|
$2.94K |
|
Petrovienam Securities Inc
VN:PSI
|
$2.94K |
|
LJQQ3F
SA:LJQQ3F
|
$2.94K |
|
Adastra Holdings Ltd.
PINK:XTXXD
|
$2.94K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in The Searle Company Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 28,663,597,000 to 29,941,998,000, a change of 1,278,401,000 (4.5%).
- Net income of 313,710,000 contributed positively to equity growth.
- Dividend payments of 25,837,000 reduced retained earnings.
- Other factors increased equity by 990,528,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | PKRs313.71 Million | +1.05% |
| Dividends Paid | PKRs25.84 Million | -0.09% |
| Other Changes | PKRs990.53 Million | +3.31% |
| Total Change | PKRs- | 4.46% |
Book Value vs Market Value Analysis
This analysis compares The Searle Company Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.12x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.93x to 1.12x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | PKRs42.64 | PKRs82.42 | x |
| 2018-06-30 | PKRs50.04 | PKRs82.42 | x |
| 2019-06-30 | PKRs59.49 | PKRs82.42 | x |
| 2020-06-30 | PKRs70.45 | PKRs82.42 | x |
| 2021-06-30 | PKRs62.93 | PKRs82.42 | x |
| 2022-06-30 | PKRs70.53 | PKRs82.42 | x |
| 2023-06-30 | PKRs73.68 | PKRs82.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently The Searle Company Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.92%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 2.09x
- Recent ROE (1.05%) is below the historical average (16.57%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 26.05% | 17.72% | 0.98x | 1.50x | PKRs1.23 Billion |
| 2017 | 25.13% | 17.70% | 0.98x | 1.45x | PKRs1.42 Billion |
| 2018 | 24.43% | 16.39% | 0.95x | 1.57x | PKRs1.59 Billion |
| 2019 | 17.14% | 12.41% | 0.85x | 1.63x | PKRs933.55 Million |
| 2020 | 16.14% | 12.21% | 0.82x | 1.62x | PKRs950.98 Million |
| 2021 | 14.39% | 14.03% | 0.53x | 1.92x | PKRs1.12 Billion |
| 2022 | 8.20% | 7.86% | 0.54x | 1.94x | PKRs-514.72 Million |
| 2023 | 1.05% | 0.92% | 0.54x | 2.09x | PKRs-2.68 Billion |
Industry Comparison
This section compares The Searle Company Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.
Industry Context
- Industry: Pharmaceuticals
- Average net assets among peers: $12,797,596,500
- Average return on equity (ROE) among peers: 16.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| The Searle Company Ltd (SEARL) | PKRs35.49 Billion | 26.05% | 0.88x | $2.95K |
| Abbott Laboratories Pakistan Ltd (ABOT) | $13.24 Billion | 20.36% | 0.53x | $31.06K |
| AGP Ltd (AGP) | $12.36 Billion | 12.66% | 1.26x | $6.39K |